CEPR - Center for Economic and Policy Research

Multimedia

En Español

Em Português

Other Languages

Home Publications Blogs Beat the Press India's Enforcement of Patent Laws Should Not Affect Drug Manufacturer's Investment Decisions

India's Enforcement of Patent Laws Should Not Affect Drug Manufacturer's Investment Decisions

Print
Wednesday, 07 July 2010 04:53

The NYT had an article on the growth on India's pharmaceutical industry in which it raised its enforcement of patent laws as an issue affecting manufacturers' decision to locate in India. There is no obvious reason why there should be any relationship between the two.

Scientists in India can gain the knowledge to manufacture patent protected drugs regardless of where the manufacturing operations are located. Placing the facilities within India would minimally increase this ability. It is difficult to believe that this additional risk would be an important consideration for drug companies although they may use their location decision as a way to coerce India and other countries to adopt more protectionist patent regimes.

Comments (2)Add Comment
...
written by izzatzo, July 07, 2010 9:28
That's exactly correct Mr Whose Your Nanny. If guns are restricted then only criminals get guns, and if pharmaceuticals are restricted then only criminals get pharmaceuticals, and if speed limits are restricted then only criminals get to speed ...

Keep your death panel patent regulation hands off my libertarian drugs.


Stupid liberals.
...
written by PeonInChief, July 07, 2010 12:11
It's possible that "better" patent protection would have a marginal impact, but the much bigger issue is India's quality control problems.

Write comment

(Only one link allowed per comment)

This content has been locked. You can no longer post any comments.

busy
 

CEPR.net
Support this blog, donate
Combined Federal Campaign #79613

About Beat the Press

Dean Baker is co-director of the Center for Economic and Policy Research in Washington, D.C. He is the author of several books, his latest being The End of Loser Liberalism: Making Markets Progressive. Read more about Dean.

Archives